Trials / Unknown
UnknownNCT06122012
To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China
A Study to Evaluate the Efficacy and Safety of HSK16149 Capsule Combined With L-carnitine Hydrochloride Tablets and Lipoic Acid Combined With L-carnitine Hydrochloride Tablets in Diabetic Peripheral Neuralgia Patients in China
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observe the effects of HSK16149 capsule combined with acetyl-L-carnitine hydrochloride tablets and lipoic acid combined with acetyl-L-carnitine hydrochloride tablets Efficacy and safety in diabetic peripheral neuralgia patients in China
Detailed description
Observe the effects of HSK16149 capsule combined with acetyl-L-carnitine hydrochloride tablets and lipoic acid combined with acetyl-L-carnitine hydrochloride tablets Efficacy and safety in diabetic peripheral neuralgia patients in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK16149 20mg BID | HSK16149 20mg BID with L-carnitine hydrochloride tablets 2 tablets TID ；Lipoic acid tablets 2 tablets BID with L-carnitine hydrochloride tablets 2 tablets TID； |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-04-30
- Completion
- 2024-05-01
- First posted
- 2023-11-08
- Last updated
- 2023-11-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06122012. Inclusion in this directory is not an endorsement.